D&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's D&A?
- Baxter International (BAX) reported D&A of $237M in Q1 2026.
- How has Baxter International's D&A changed year-over-year?
- Baxter International's D&A decreased by 4.0% year-over-year, from $247M to $237M.
- What is the long-term trend for Baxter International's D&A?
- Over 4 years (2021 to 2025), Baxter International's D&A has grown at a 3.1% compound annual growth rate (CAGR), from $867M to $981M.
- What does D&A mean?
- The annual non-cash expense representing the gradual loss of value of company assets over time.
- How do you interpret D&A?
- Higher values indicate significant capital investment in infrastructure or recent acquisitions, while lower values may suggest aging assets or limited capital expenditure.
- How does D&A compare across companies?
- Standard across all capital-intensive industries; peers in medical devices typically show high levels due to manufacturing equipment and acquired technology.